Search

everythinglearnresearchcommunity

for

Search:↓

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Hair follicle culture helps develop new treatments for hair loss.

Skin lymphatic vessels are essential for hair growth.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Non-immune factors play a significant role in alopecia areata.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Effective treatments for severe alopecia areata are still lacking.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Platelet-rich treatments can help improve wound healing and tissue repair.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Acne is caused by multiple factors including oil production, bacteria, inflammation, and possibly diet and environment.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Low vitamin D levels are common in people with Alopecia Areata.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.